SCHEMBL20914535

SCHEMBL20914535

COc1c(C)cnc(CN(C(=O)O)c2cccc(CO[Si](C)(C)C(C)(C)C)c2)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGXT P21549 1/20 0.38
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
SHMT2 P34897 1/20 0.33
HSP90AA1 P07900 3/20 0.33
LNPEP Q9UIQ6 1/20 0.33
ALDH1A1 P00352 4/20 0.32
MRGPRX4 Q96LA9 2/20 0.32
JAK2 O60674 1/20 0.32
HTT P42858 1/20 0.32
PAX8 Q06710 1/20 0.32
PDK1 Q15118 3/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
MAPK1 P28482 2/20 0.32
PDE10A Q9Y233 1/20 0.32
LMNA P02545 1/20 0.32
SIRT5 Q9NXA8 1/20 0.32
WDR5 P61964 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20937136 0.90 HDAC1 (0.38) AGXTNPC1RAB9AKMT2AMEN1
SCHEMBL20914502 0.85 RAB9A (0.42) AGXTNPC1RAB9AKMT2AMEN1
SCHEMBL20914648 0.84 AGXT (0.35) AGXTKMT2AALDH1A1HTTPDK1
SCHEMBL20914547 0.81 RAB9A (0.47) AGXTNPC1RAB9AKMT2AMEN1
SCHEMBL20914591 0.81 KMT2A (0.41) NPC1RAB9AKMT2AMEN1HSP90AA1
SCHEMBL20914570 0.80 NPC1 (0.41) AGXTNPC1RAB9AKMT2AMEN1
SCHEMBL20914433 0.80 AGXT (0.46) AGXTKMT2ASHMT2HSP90AA1LNPEP
SCHEMBL22134498 0.80 ATP4A (0.40) AGXTNPC1RAB9AKMT2ASHMT2
SCHEMBL20914477 0.80 KMT2A (0.40) AGXTNPC1RAB9AKMT2AMEN1
SCHEMBL20914490 0.80 AGXT (0.40) AGXTNPC1RAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates THE SCRIPPS RESEARCH INSTITUTE (US) 2020-06-30 US disclosed
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE 2019-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS AHR, PAH, DOHH AGXT 2288/4885NPC1 3798/4885RAB9A 2426/4885
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates PAH, AHR, DDC AGXT 2246/4885NPC1 3848/4885RAB9A 2261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.